(19)
(11) EP 4 514 847 A1

(12)

(43) Date of publication:
05.03.2025 Bulletin 2025/10

(21) Application number: 23795446.6

(22) Date of filing: 26.04.2023
(51) International Patent Classification (IPC): 
C07K 16/24(2006.01)
A61K 39/395(2006.01)
A61P 35/02(2006.01)
 C07K 16/46(2006.01)
A61K 51/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C07K 16/2878; C07K 16/2809; C07K 2317/92; C07K 2317/622; C07K 2317/31; C07K 2317/73
(86) International application number:
PCT/CN2023/090744
(87) International publication number:
WO 2023/208014 (02.11.2023 Gazette 2023/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 28.04.2022 CN 202210460302

(71) Applicant: Beijing Mabworks Biotech Co., Ltd
Beijing 100176 (CN)

(72) Inventors:
  • LIU, Fangjie
    Beijing 100176 (CN)
  • LI, Jiangmei
    Beijing 100176 (CN)
  • HU, Wenqi
    Beijing 100176 (CN)
  • LI, Feng
    Beijing 100176 (CN)

(74) Representative: Krauss, Jan 
SKM-IP PartGmbB Oberanger 45
80331 München
80331 München (DE)

   


(54) ANTIBODIES BINDING BCMA AND CD3 AND USES THEREOF